AOE Codes - Mayo Clinic Laboratories
AOE Codes Some tests, such as microbiology cultures and those that determine heavy metal ion concentration, require additional information with the laboratory order. This information, in the form of Ask at Order Entry Question...
Week in Review: January 20 - Insights
Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise
CPT codes and LOINC update: October 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of October.
The following resources can be used as a reminder for staff on the order of putting on and taking off, and reuse of PPE.
Clinical Application of Next-Generation Sequencing (NGS) Testing - Insights
October 8, 2017 | Rochester, Minnesota This symposium is designed for any provider who treats patients with hematologic malignancies (e.g., oncologists, hematologists, and physician assistants), pathologists, hematopathologists,...
Precision oncology therapeutics - Insights
Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.
Whole genome sequencing - Insights
Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
Understanding the difference between benign and malignant adrenal tumors has alway been difficult; this new assay will assist with this medical challenge.
Lyme Neuroborreliosis - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss diagnostic testing options for patients with suspected neuroinvasive Lyme disease or Lyme neuroborreliosis.